Zoekresultaten - Kerin, M.J.
- Toon 1 - 20 resultaten van 24
- Ga naar de volgende pagina
-
1
Postoperative fluid therapy--put not thy faith in dextrose saline: discussion paper. door Kruegener, G H, Kerin, M J, MacFie, J
Gepubliceerd in 1991Text -
2
-
3
Water-clear cell adenoma: A rare form of hyperparathyroidism() door Piggott, R.P., Waters, P.S., Ashraf, J., Colesky, F., Kerin, M.J.
Gepubliceerd in 2013Text -
4
-
5
-
6
MicroRNAs as Novel Biomarkers for Breast Cancer door Heneghan, H. M., Miller, N., Lowery, A. J., Sweeney, K. J., Kerin, M. J.
Gepubliceerd in 2010Text -
7
-
8
An evaluation of preoperative CA 15-3 measurement in primary breast carcinoma. door O'Hanlon, D. M., Kerin, M. J., Kent, P., Maher, D., Grimes, H., Given, H. F.
Gepubliceerd in 1995Text -
9
Laparoscopic cholecystectomy: potential for missed pathology. door O'Hanlon, D. M., Kerin, M. J., O'Donoghue, J. M., Doyle, J. P., Flynn, J. R.
Gepubliceerd in 1994Text -
10
-
11
Clinical utility of the 21-gene assay in predicting response to neoadjuvant endocrine therapy in breast cancer: A systematic review and meta-analysis door Davey, M.G., Ryan, É.J., Boland, M.R., Barry, M.K., Lowery, A.J., Kerin, M.J.
Gepubliceerd in 2021Text -
12
-
13
-
14
-
15
Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options door McAnena, Peter F., Brown, James AL, Ramli, A., Curran, C., Malone, C., McLaughlin, R., Barry, K., JAL, Brown, Kerin, M. J.
Gepubliceerd in 2018Text -
16
Correction to: Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options door McAnena, Peter F., McGuire, Andrew, Ramli, A., Curran, C., Malone, C., McLaughlin, R., Barry, K., Brown, James A. L., Kerin, M. J.
Gepubliceerd in 2018Text -
17
Quantifying Tip60 (Kat5) stratifies breast cancer door McGuire, A., Casey, M. C., Shalaby, A., Kalinina, O., Curran, C., Webber, M., Callagy, G., Holian, E., Bourke, E., Kerin, M. J., Brown, J. A. L.
Gepubliceerd in 2019Text -
18
Impact of receptor phenotype on nodal burden in patients with breast cancer who have undergone neoadjuvant chemotherapy door Boland, M. R., McVeigh, T. P., O'Flaherty, N., Gullo, G., Keane, M., Quinn, C. M., McDermott, E. W., Lowery, A. J., Kerin, M. J., Prichard, R. S.
Gepubliceerd in 2017Text -
19
Quantifying Argonaute 2 (Ago2) expression to stratify breast cancer door Casey, M.C., Prakash, A., Holian, E., McGuire, A., Kalinina, O., Shalaby, A., Curran, C., Webber, M., Callagy, G., Bourke, E., Kerin, M. J., Brown, J. A.
Gepubliceerd in 2019Text -
20